Colgate-Palmolive Co. logo

Colgate-Palmolive Co. (CL)

Market Closed
5 Dec, 20:00
NYSE NYSE
$
78. 07
+0.47
+0.61%
$
64.52B Market Cap
40.3 P/E Ratio
2% Div Yield
4,510,475 Volume
3.21 Eps
$ 77.6
Previous Close
Day Range
77.24 78.21
Year Range
74.55 100.18
Want to track CL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 48 days
Colgate-Palmolive (CL) is a Top-Ranked Momentum Stock: Should You Buy?

Colgate-Palmolive (CL) is a Top-Ranked Momentum Stock: Should You Buy?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 year ago
Here is Why Growth Investors Should Buy Colgate-Palmolive (CL) Now

Here is Why Growth Investors Should Buy Colgate-Palmolive (CL) Now

Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago
5 Consumer Staples Stocks to Buy for a Stable Portfolio

5 Consumer Staples Stocks to Buy for a Stable Portfolio

We have narrowed our search to five consumer staples stocks with strong growth potential for 2024. These stocks are: CL, MKC, PEP, TSN, FRPT.

Zacks | 1 year ago
Why Colgate-Palmolive (CL) is a Great Dividend Stock Right Now

Why Colgate-Palmolive (CL) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colgate-Palmolive (CL) have what it takes?

Zacks | 1 year ago
3 High-Quality Value Stocks You Should Know

3 High-Quality Value Stocks You Should Know

Investors looking for worthwhile companies to add to their portfolios should consider a few factors that make up a ‘high-quality' stock. The company's product or service and the relative moat around them are among these factors.

Marketbeat | 1 year ago
Here's Why Colgate's (CL) Strategic Efforts Appear Good

Here's Why Colgate's (CL) Strategic Efforts Appear Good

Colgate-Palmolive Company (CL Quick QuoteCL - Free Report) stock is doing well on the bourses, thanks to its robust strategic efforts. The company has been gaining from pricing and productivity initiatives for a while now. Its innovation strategy and shareholder-friendly moves also bode well. Shares of this renowned consumer goods company have increased 24.4% in the past six months compared with the industry’s 15.1% upside. A Growth Score of A adds strength to this current Zacks Rank #2 (Buy) company.Let’s Delve DeeperColgate’s innovation strategy is focused on growing in adjacent categories and product segments. It is focused on the premiumization of its Oral Care portfolio through major innovations. Backed by premium innovation, products including CO. by Colgate, Colgate Elixir toothpaste and Colgate enzyme whitening toothpaste have been performing well.Also, at-home whitening and professional whitening products bode well. Its Oral Care business has also been performing well. Some other notable efforts include the continued expansion of the Naturals and Therapeutics divisions, as well as the Hello Products LLC buyout. Colgate has been gaining from strong pricing and the benefits of funding-the-growth program and other productivity initiatives. The company has been implementing aggressive pricing for the last few quarters, which boosted margins in the first quarter. The gross profit margin expanded 310 basis points (bps) to 60% on both GAAP basis and adjusted basis. As a result, adjusted basis earnings advanced 18% from the prior-year period.The company is experiencing solid momentum in its business, which led to a robust top-line performance in the first quarter. Also, accelerated revenue-growth management plans aided Colgate’s organic sales in the quarter. Net sales jumped 6.2% year over year while the metric advanced 9.8% on an organic basis. The sales momentum was mainly driven by organic sales growth in each of the six divisions and across all four categories. Further, total volumes were up 1.3% year over year on an organic and reported basis, attributed to sequential growth in North America and Europe. Meanwhile, pricing improved 8.5%, backed by positive pricing across all six divisions.Image Source: Zacks Investment ResearchDriven by the impressive results, management raised its view for 2024. It anticipates net sales growth in the range of 2-5% compared with 1-4% growth mentioned earlier. The company expects organic sales growth in the band of 5-7% compared with 3-5% mentioned earlier. Colgate expects adjusted earnings per share to grow in the mid to high-single digits. CL foresees gross profit margin expansion on both GAAP and adjusted basis, driven by continued pricing gains, benefits from revenue growth management initiatives and strength in the funding-the-growth program.Regarding its shareholder-friendly efforts, Colgate is committed to rewarding shareholders with share buybacks and dividend payouts. Recently, it paid a dividend of 50 cents a share. On an annualized basis, the dividend rate is $2.00 per share, up from $1.92 paid previously. Markedly, the company has paid uninterrupted dividends since 1895. Other Stocks to ConsiderThe Chef’s Warehouse (CHEF Quick QuoteCHEF - Free Report) , which engages in the distribution of specialty food products, currently carries a Zacks Rank of 2. CHEF has a trailing four-quarter earnings surprise of 3.2%, on average. The Zacks Consensus Estimate for The Chef’s Warehouse’s current fiscal year sales and earnings suggests growth of 8.7% and 4.7%, respectively, from the year-ago reported numbers.Vital Farms Inc. (VITL Quick QuoteVITL - Free Report) offers a range of produced pasture-raised foods. It currently carries a Zacks Rank of 2. VITL has a trailing four-quarter average earnings surprise of 155.4%.The consensus estimate for Vital Farms’ current financial-year sales and earnings suggests growth of 18.6% and 35.6%, respectively, from the year-ago reported numbers.Utz Brands Inc. (UTZ Quick QuoteUTZ - Free Report) , which manufactures a diverse portfolio of salty snacks, currently carries a Zacks Rank of 2. UTZ has a trailing four-quarter earnings surprise of 2.6%, on average.The Zacks Consensus Estimate for Utz Brands’ current financial-year earnings suggests growth of 15.8% from the year-ago reported numbers. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>

Zacks | 1 year ago
Looking for a Growth Stock? 3 Reasons Why Colgate-Palmolive (CL) is a Solid Choice

Looking for a Growth Stock? 3 Reasons Why Colgate-Palmolive (CL) is a Solid Choice

Colgate-Palmolive (CL) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks | 1 year ago